We serve Chemical Name:4-amino-3-ethoxybenzamide CAS:917909-47-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-amino-3-ethoxybenzamide
CAS.NO:917909-47-8
Synonyms:Benzamide,4-amino-3-ethoxy;4-amino-3-ethoxy-benzamide;3-ethoxy-4-amino-benzamide
Molecular Formula:C9H12N2O2
Molecular Weight:180.20400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:79.33000
Exact Mass:180.09000
LogP:2.23180
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Benzamide,4-amino-3-ethoxy chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-ethoxy-4-amino-benzamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-amino-3-ethoxy-benzamide Use and application,Benzamide,4-amino-3-ethoxy technical grade,usp/ep/jp grade.
Related News: The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. 4-amino-3-ethoxybenzamide manufacturer Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology. 4-amino-3-ethoxybenzamide supplier Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities. 4-amino-3-ethoxybenzamide vendor The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. 4-amino-3-ethoxybenzamide factory The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.
